CYCLERION THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $48.2M | $54.0M |
| FY2022 | — | $10.5M | $13.4M |
| FY2023 | — | $11.3M | $7.6M |
| FY2024 | — | $8.9M | $3.2M |
| FY2025 | — | $9.1M | $3.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $48.2M | $54.0M |
| FY2022 | — | $10.5M | $13.4M |
| FY2023 | — | $11.3M | $7.6M |
| FY2024 | — | $8.9M | $3.2M |
| FY2025 | — | $9.1M | $3.2M |